Back to News
Market Impact: 0.45

Should You Buy, Sell or Hold UiPath Stock Ahead of Q2 Earnings?

PATHMSFTAMZN
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsTechnology & InnovationMarket Technicals & FlowsInvestor Sentiment & Positioning
Should You Buy, Sell or Hold UiPath Stock Ahead of Q2 Earnings?

UiPath (PATH) is poised to report Q2 fiscal 2026 earnings with consensus estimates projecting 8 cents EPS, a significant year-over-year increase, and $347.8 million in revenue, a 10% rise, building on a strong historical earnings surprise record. However, despite strategic partnerships and 12% annual recurring revenue (ARR) growth, a low probability of an earnings beat is indicated for Q2, primarily due to an anticipated 19.1% year-over-year decline in license services revenue. This, coupled with the stock's 13.7% underperformance against its industry and unchanged analyst EPS estimates, suggests a cautious investment approach, advising investors to await a clearer entry point.

Analysis

UiPath (PATH) faces a mixed outlook ahead of its Q2 fiscal 2026 earnings report, creating a complex risk/reward scenario. While consensus estimates project strong year-over-year growth, with revenues expected to rise 10% to $347.8 million and EPS to surge over 100% to 8 cents, significant underlying headwinds challenge the bullish case. A primary concern is the anticipated 19.1% year-over-year decline in license services revenue, which is not fully offset by the projected 9.7% growth in subscription revenues. This shift in revenue mix, coupled with a proprietary model indicating a low probability of an earnings beat and stagnant analyst EPS estimates for the past 60 days, points to a lack of near-term catalysts. The stock's performance reflects this uncertainty, having fallen 13.7% in a year, drastically underperforming its industry's 39.6% gain. Although strategic partnerships with Microsoft and Amazon bolster its long-term credibility and annual recurring revenue (ARR) has grown 12% to $1.6 billion, the stock's discounted valuation (18.87X P/E vs. 38.82X for the industry) appears to price in these immediate operational challenges.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo